CLINICAL AND IMMUNOBIOCHEMICAL MARKERS IN THE DIAGNOSIS OF BRONCHIAL ASTHMA COMBINED WITH TYPE 2 DIABETES MELLITUS

dc.contributor.author	Faizullaeva N. Ya.
dc.contributor.author	Mukhtorov Sh. M.
dc.contributor.author	Raufov A. A.
dc.contributor.author	Nabieva U. P.
dc.contributor.author	Yarmukhammedov A. S.
dc.date.accessioned	2025-12-29T13:43:00Z
dc.date.issued	2025-11-13
dc.description.abstract	The aim of the study was to investigate clinical, laboratory and immunobiochemical markers in patients with bronchial asthma (BA) combined with type 2 diabetes mellitus (T2DM). A comparative analysis of clinical manifestations, carbohydrate metabolism parameters, fibrinolysis and the antioxidant system was performed.
dc.format	application/pdf
dc.identifier.uri	https://webofjournals.com/index.php/12/article/view/5384
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/20836
dc.language.iso	eng
dc.publisher	Web of Journals Publishing
dc.relation	https://webofjournals.com/index.php/12/article/view/5384/5413
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	Web of Scientists and Scholars: Journal of Multidisciplinary Research; Vol. 3 No. 11 (2025): WOSS; 6-16
dc.source	2938-3811
dc.subject	Bronchial asthma, type 2 diabetes mellitus, immunobiochemical markers, superoxide dismutase, tPA, PAI-1, diagnostics.
dc.title	CLINICAL AND IMMUNOBIOCHEMICAL MARKERS IN THE DIAGNOSIS OF BRONCHIAL ASTHMA COMBINED WITH TYPE 2 DIABETES MELLITUS
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: ya_2025_clinical_and_immunobiochemical_markers_i.pdf
item.page.filesection.size: 503.96 KB
item.page.filesection.format: Adobe Portable Document Format